Drug name - Prialt
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8653033 | TERSERA | Method for administering omega-conopeptide |
Oct, 2024
(1 year, 9 months from now) | |
| US8765680 | TERSERA | Method for administering omega-conopeptide |
Oct, 2024
(1 year, 9 months from now) | |
| US9707270 | TERSERA | Method for administering ω-conopeptide |
Oct, 2024
(1 year, 9 months from now) | |
Drugs and Companies using ZICONOTIDE ACETATE ingredient
Market Authorisation Date: 28 December, 2004
Treatment: Analgesia; Treatment of pain; Treatment of severe chronic pain via intrathecal infusion of ziconotide in patients also receiving morphine
Dosage: INJECTABLE;INTRATHECAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 100MCG/1ML (100MCG/ML) | INJECTABLE;INTRATHECAL | Prescription |
| 200MCG/2ML (100MCG/ML) | INJECTABLE;INTRATHECAL | Discontinued |
| 500MCG/20ML (25MCG/ML) | INJECTABLE;INTRATHECAL | Prescription |
| 500MCG/5ML (100MCG/ML) | INJECTABLE;INTRATHECAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.